Efferocytosis in oral squamous cell carcinoma

Journal of Oral and Maxillofacial Pathology

Volumn 20, Issue 2, 2016, Pages 170-172

  Sarode, Gargi S ^a  

^a DR D Y PATIL DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979498212     PISSN: 0973029X     EISSN: 1998393X     Source Type: Journal    
DOI: 10.4103/0973-029X.185918     Document Type: Article

References (18)

1. Sarode SC, Sarode GS, Karmarkar S, Tupkari JV. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011;47:920-1.
2. Sarode SC, Sarode GS, Tupkari JV. Oral potentially malignant disorders: Precising the definition. Oral Oncol 2012;48:759-60.
3. Sarode GS, Sarode SC, Karmarkar S. Complex cannibalism: An unusual finding in oral squamous cell carcinoma. Oral Oncol 2012;48:e4-6.
4. Sarode SC, Sarode GS. Neutrophil-tumor cell cannibalism in oral squamous cell carcinoma. J Oral Pathol Med 2014;43:454-8.
5. Sarode SC, Sarode GS. Cellular cannibalism in central and peripheral giant cell granuloma of the oral cavity can predict biological behavior of the lesion. J Oral Pathol Med 2014;43:459-63.
6. Sarode GS, Sarode SC. E6 oncoprotein interaction with paxillin and FAK. Oral Oncol 2014;50:e17.
7. Sarode GS, Sarode SC, Anand R, Patil S, Rao R, Augustine D. Psychological intervention in head and neck cancer: From molecular standpoint. World J Dent 2014;5:249-50.
8. Sarode GS, Sarode SC, Patil S. Accept and respect the uniqueness of oral cancer. World J Dent 2014;5:v-vi.
9. Sarode SC, Sarode GS. Is oral cancer unique in terms of chemotherapeutic and targeted drug metabolism J Oral Maxillofac Surg 2015;73:4-6.
10. Henson PM. The final step in programmed cell death: Phagocytes carry apoptotic cells to the grave. Essays Biochem 2003;39:105-17.
11. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005;123:321-34.
12. Vandivier RW, Henson PM, Douglas IS. Burying the dead: The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006;129:1673-82.
13. Cullen SP, Henry CM, Kearney CJ, Logue SE, Feoktistova M, Tynan GA, et al. Fas/CD95induced chemokines can serve as "find-me" signals for apoptotic cells. Mol Cell 2013;49:1034-48.
14. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-16.
15. Borisenko GG, Matsura T, Liu SX, Tyurin VA, Jianfei J, Serinkan FB, et al. Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells - existence of a threshold. Arch Biochem Biophys 2003;413:41-52.
16. Gumienny TL, Brugnera E, Tosello-Trampont AC, Kinchen JM, Haney LB, Nishiwaki K, et al. CED12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001;107:27-41.
17. Stanford JC, Young C, Hicks D, Owens P, Williams A, Vaught DB, et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. J Clin Invest 2014;124:4737-52.
18. Nguyen KQ, Tsou WI, Calarese DA, Kimani SG, Singh S, Hsieh S, et al. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity. J Biol Chem 2014;289:25737-49.